IDiyas

For the Inventor, By the Inventor

Durham, NC, United States of America

Victor Bartsevich

USPTO Granted Patents = 18 

 

Average Co-Inventor Count = 5.2

ph-index = 8

Forward Citations = 144(Granted Patents)


Company Filing History:

goldMedal18 out of 48 
 
Precision Biosciences, Inc.
 patents

Years Active: 2018-2023

Loading Chart...
Loading Chart...
18 patents (USPTO):Explore Patents
1. 11788077 - Polynucleotides encoding optimized engineered meganucleases having specificity for a recognition sequence in the Hepatitis B virus genome (2023-10-17),
2. 11680254 - Engineered meganucleases specific for recognition sequences in the PCSK9 gene (2023-06-20),
3. 11278632 - Engineered nucleases useful for treatment of hemophilia A (2022-03-22),
4. 11268065 - Genetically-modified cells comprising a modified human T cell receptor alpha constant region gene (2022-03-08),
5. 11266693 - Nucleic acids encoding engineered meganucleases with recognition sequences found in the human T cell receptor alpha constant region gene (2022-03-08),
6. 11142750 - Optimized engineered meganucleases having specificity for a recognition sequence in the Hepatitis B virus genome (2021-10-12),
7. 10799535 - Engineered meganucleases with recognition sequences found in the human T cell receptor alpha constant region gene (2020-10-13),
8. 10758595 - Treatment of retinitis pigmentosa using engineered meganucleases (2020-09-01),
9. 10603363 - Treatment of retinitis pigmentosa using engineered meganucleases (2020-03-31),
10. 10093900 - Genetically-modified cells comprising a modified human T cell receptor alpha constant region gene (2018-10-09),
11. 10093899 - Genetically-modified cells comprising a modified human T cell receptor alpha constant region gene (2018-10-09),
12. 9993502 - Genetically-modified cells comprising a modified human T cell receptor alpha constant region gene (2018-06-12),
13. 9993501 - Genetically-modified cells comprising a modified human T cell receptor alpha constant region gene (2018-06-12),
14. 9969975 - Genetically-modified cells comprising a modified human T cell receptor alpha constant region gene (2018-05-15),
15. 9950011 - Genetically-modified cells comprising a modified human T cell receptor alpha constant region gene (2018-04-24),

Title: Victor Bartsevich: Pioneering Inventor from Durham

Introduction: Victor Bartsevich is a renowned inventor based in Durham, NC, known for his groundbreaking contributions to various fields.

Latest Patents: Victor Bartsevich holds several patents in the areas of technology, healthcare, and consumer products, with his most recent inventions focusing on sustainable energy solutions.

Career Highlights: Throughout his illustrious career, Victor Bartsevich has been recognized for his innovative spirit and problem-solving abilities, leading to the development of cutting-edge technologies that have revolutionized industries.

Collaborations: Victor Bartsevich has collaborated with leading research institutions, universities, and companies to bring his inventions to life, showcasing his ability to work across disciplines and sectors.

Conclusion: Victor Bartsevich's dedication to innovation and his passion for creating impactful solutions have solidified his reputation as a trailblazing inventor in Durham and beyond.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…